{"controller"=>"catalog", "action"=>"show", "id"=>"234355445"}
  • EN
  • DA

Danish NationalResearch Database

  • Search Publications & Researchers
  • Open Access Indicator
  • Publications
  • Researchers
Example Finds records
water{} containing the word "water".
water supplies"{}" containing the phrase "water supplies".
author:"Doe, John"author:"{}" containing the prase "Doe, John" in the author field.
title:IEEEtitle:{} containing the word "IEEE" in the title field.
Need more help? Advanced search tutorial
  • Selected (0)
  • History

PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection

    • Save to Mendeley
    • Export to BibTeX
    • Export to RIS
    • Email citation
Authors:
  • Rembeck, Karolina ;
    Close
    unknown
  • Maglio, Cristina ;
    Close
    unknown
  • Lagging, Martin ;
    Close
    unknown
  • Brehm Christensen, Peer ;
    Close
    Infectious Diseases, Department of Clinical Research, Faculty of Health Sciences, SDU
  • Färkkilä, Martti ;
    Close
    unknown
  • Langeland, Nina ;
    Close
    unknown
  • Rauning Buhl, Mads ;
    Close
    unknown
  • Pedersen, Court ;
    Close
    Infectious Diseases, Department of Clinical Research, Faculty of Health Sciences, SDU
  • Mørch, Kristine ;
    Close
    unknown
  • Norkrans, Gunnar ;
    Close
    unknown
  • Hellstrand, Kristoffer ;
    Close
    unknown
  • Lindh, Magnus ;
    Close
    unknown
  • Pirazzi, Carlo ;
    Close
    unknown
  • Burza, Maria Antonella ;
    Close
    unknown
  • Romeo, Stefano ;
    Close
    unknown
  • Westin, Johan ;
    Close
    unknown
  • Group, For The Nordynamic
    Close
    unknown
DOI:
10.1186/1471-2350-13-82
Abstract:
ABSTRACT: BACKGROUND: Hepatic steatosis in HCV patients has been postulated as a risk factor associated with a higher frequency of fibrosis and cirrhosis. A single genetic variant, PNPLA3 I148M, has been widely associated with increased hepatic steatosis. Previous studies of the PNPLA3 I148M sequence variant in HCV infected individuals have reported an association between this variant and prevalence of steatosis, fibrosis, and cirrhosis. To evaluate the impact of PNPLA3 I148M variant on metabolic traits and treatment response in HCV genotype 2 and 3 infected patients. METHODS: Three hundred and eighty-two treatment naive HCV genotype 2 or 3 infected patients were included in a phase III, open label, randomized, multicenter, investigator-initiated trial (the NORDynamIC study), in which pretreatment liver biopsies were mandatory. PNPLA3I148M genotyping was performed in a total of 359 Caucasian patients. RESULTS: In HCV genotype 2 infected patients carrying the PNPLA3 148 M allele, there was significantly increased insulin resistance (P = 0.023) and lower viral load (P = 0.005) at baseline as well as the first seven days of antiviral treatment. These results were not observed in HCV genotype 3 infected patients. CONCLUSIONS: Our results suggest a possible association between the PNPLA3 148 M allele and insulin resistance as well as baseline viral load in HCV genotype 2, but not in genotype 3.
Type:
Journal article
Language:
English
Published in:
B M C Medical Genetics, 2012, Vol 13, Issue 1
Main Research Area:
Medical science
Publication Status:
Published
Review type:
Peer Review
Submission year:
2012
Scientific Level:
Scientific
ID:
234355445

Full text access

  • Doi Get publisher edition via DOI resolver
Checking for on-site access...

On-site access

At institution

  • University southern denmark

Metrics

Feedback

Sitemap

  • Search
    • Statistics
    • Tutorial
    • Data
    • FAQ
    • Contact
  • Open Access
    • Overview
    • Development
    • FAQ
    • Contact
  • About
    • Institutions
    • Release History
    • Cookies and privacy policy

Copyright © 1998–2018.

Fivu en